<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
PRTA
Prothena
$
()


  • Prothena announces review on birtamimab mechanism

    4/15/2024 - 16:13pm
  • Prothena names David Ford chief people officer

    3/4/2024 - 16:07pm
  • Prothena files to sell ordinary shares, no amount given

    2/22/2024 - 17:31pm
  • Prothena names Daniel Welch as Director and Chair Designate

    2/21/2024 - 16:26pm
  • Prothena price target lowered by $18 at Oppenheimer, here's why

    2/20/2024 - 07:47am
  • Prothena price target raised by $4 at JMP Securities, here's why

    2/16/2024 - 06:20am
  • Prothena reports Q4 EPS ($1.26), consensus ($1.22)

    2/15/2024 - 16:10pm
  • Prothena just downgraded at BofA, here's why

    1/30/2024 - 06:44am
  • Prothena price target lowered by $7 at RBC Capital, here's why

    1/25/2024 - 09:30am
  • Prothena put volume heavy and directionally bearish

    1/17/2024 - 12:15pm
  • What You Missed On Wall Street On Monday

    1/8/2024 - 16:50pm
  • What You Missed On Wall Street This Morning

    1/8/2024 - 12:09pm
  • Prothena remains on track with partnered programs, provides updates

    1/8/2024 - 10:05am
  • The biotech stocks to own in 2024, according to Piper Sandler

    1/2/2024 - 12:13pm
  • Biotech Alert: Searches spiking for these stocks today

    12/21/2023 - 10:52am
dynamic_feed Breaking News